A Phase 2 study of pioglitazone in cancer cachexia
Active, Not Recruiting Phase 2 NCT05919147
Study Description
Evaluating the effects of the diabetes drug pioglitazone on muscle health in cancer patients with cachexia
Study Details
- Registry ID:
- NCT05919147
- Conditions:
- Lung Cancer
- Phase:
- Phase 2
- Target Enrollment:
- 24 participants
- Start Date:
- Age Range:
- 18–999 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
Pennington Biomedical Research Center
Baton Rouge, Louisiana, United States
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.